Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P960030/S081

IsoFlex (1944)

ABBOTT MEDICAL · Decision date Aug 27, 2025

FDA DECISIONP960030/S081

What did the FDA approve?

FDA records P960030/S081 as a supplement to PMA P960030, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Aug 27, 2025.

FDA approval order statement

expansion of MR Conditial labeling for IsoFlex model 1944 pacing leads and additional Quartet LV pacing leads (75cm and 92cm) when combined with Avant, Gallant, Entrant, and Neutrino NxT implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds).
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Aug 27, 2025
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record

Regulatory record facts

Identifier
P960030/S081
Regulatory pathway
PMA supplement
Product code
NVN
Decision code
APPR
Decision date
Aug 27, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes.

Product code
NVN
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P960030/S081 received

    Application receipt date recorded by FDA.

  2. P960030/S081 · FDA decision

    Real-Time Process

  3. P960030/S084 · Related supplement

    UltiPace Low Voltage LPA1231, Tendril Low Voltage 2088TC, OptiSense Low Voltage 1999, Isoflex Low Voltage 1944/1948, Ten

Timeline entries are records held by MedtechLedger for P960030. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P960030

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementNov 20, 2025FDA
IsoFlexP960030/S080
ABBOTT MEDICALPMA supplementFeb 19, 2026FDA
ABBOTT MEDICALPMA supplementJun 11, 2026FDA
IsoFlex LeadsP960030/S085
ABBOTT MEDICALPMA supplementJun 26, 2026FDA

Explore the linked device profile

Other records with product code NVN

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic Cardiac Rhythm Disease ManagementPMA supplementOct 16, 2026FDA
ABBOTT MEDICALPMA supplementOct 9, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementAug 5, 2026FDA
ABBOTT MEDICALPMA supplementJun 26, 2026FDA
Medtronic Cardiac Rhythm Disease ManagementPMA supplementJun 24, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
15900 Valley View Ct., Sylmar, CA, 91335

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records